Company: UHS
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0000950170-25-049925
Chunk: 30

Company: UNIVERSAL HEALTH SERVICES INC
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 30
---
 Deferred Compensation                                       | 30 |
| Retirement Benefits                                         | 31 |
| Benefits                                                    | 32 |
| Summary                                                     | 33 |
| Compensation Committee Report                               | 33 |
| Compensation Committee Interlocks and Insider Participation | 33 |

| 20                                                   |
| Universal Health Services, Inc. 2025 Proxy Statement |

| Executive Compensation |

Our 2024 Performance and Highlights

During 2024, our adjusted net income attributable to UHS (see note A. below) increased to $1.13 billion, or $16.61 per diluted share, as compared to $739.4 million, or $10.54 per diluted, share during 2023.

Our net revenues increased by 10.8% to $15.83 billion during 2024 as compared to $14.28 billion during 2023.

Net revenues generated from our acute care services, on a same facility basis, increased 8.5% during 2024, as compared to 2023. During 2024, adjusted admissions (adjusted for outpatient activity) at our acute care hospitals, on a same facility basis, increased 2.9% and adjusted patient days increased 1.8%, as compared to 2023.

Net revenues generated from our behavioral health care services, on a same facility basis, increased 10.7% during 2024, as compared to 2023. During 2024, adjusted admissions at our behavioral health care hospitals, on a same facility basis, increased 0.7% and adjusted patient days increased 1.7%, as compared to 2023.

We invested more than $652 million in our acute care segment, and approximately $286 million in our behavioral health care segment, to construct, expand, equip and improve our facilities.

During 2024, pursuant to our share repurchase program, we repurchased approximately 2.98 million shares at an aggregate cost of approximately $598.5 million.

Adjusted net income and adjusted net income per diluted share for 2024 and 2023 were publicly disclosed and reconciled to our reported results for each year on the Schedule of Non-GAAP Supplemental Consolidated Statements of Income Information, included with our earnings for the years ended December 31, 2024 and 2023, as filed on Form 8-K on February 27, 2025. Annex A contains a reconciliation of these non-GAAP financial measures to financial measurements determined in accordance with GAAP.

The following are a few